Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 510 | 2018 |
Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial D Yahav, E Franceschini, F Koppel, A Turjeman, T Babich, R Bitterman, ... Clinical Infectious Diseases 69 (7), 1091-1098, 2019 | 346 | 2019 |
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel T Brosh-Nissimov, E Orenbuch-Harroch, M Chowers, M Elbaz, L Nesher, ... Clinical Microbiology and Infection 27 (11), 1652-1657, 2021 | 324 | 2021 |
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel P Kuodi, Y Gorelik, H Zayyad, O Wertheim, KB Wiegler, K Abu Jabal, ... npj Vaccines 7 (1), 101, 2022 | 170 | 2022 |
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial Y Dickstein, J Lellouche, M Ben Dalak Amar, D Schwartz, A Nutman, ... Clinical Infectious Diseases 69 (5), 769-776, 2019 | 98 | 2019 |
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 80 | 2021 |
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: In vitro synergism is not associated with better clinical outcomes A Nutman, J Lellouche, E Temkin, G Daikos, A Skiada, ... Clinical Microbiology and Infection 26 (9), 1185-1191, 2020 | 64 | 2020 |
Revival of old antibiotics: needs, the state of evidence and expectations H Zayyad, N Eliakim-Raz, L Leibovici, M Paul International journal of antimicrobial agents 49 (5), 536-541, 2017 | 59 | 2017 |
Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study K Hussein, G Rabino, O Feder, H Eghbaryeh, H Zayyad, G Sviri, ... Acta Neurochirurgica 161, 517-524, 2019 | 48 | 2019 |
Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel MJ Cohen, Y Oster, AE Moses, A Spitzer, S Benenson, A Abu-Ahmad, ... JAMA Network Open 5 (8), e2224657-e2224657, 2022 | 35 | 2022 |
The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 32 | 2021 |
ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 23 | 2022 |
Bacteremia Duration Study Group: Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: A noninferiority randomized controlled trial D Yahav, E Franceschini, F Koppel, A Turjeman, T Babich, R Bitterman, ... Clin Infect Dis 69 (7), 1091-1098, 2019 | 21 | 2019 |
Colistin resistance development following colistin-meropenem combination therapy versus colistin monotherapy in patients with infections caused by carbapenem-resistant organisms Y Dickstein, J Lellouche, D Schwartz, A Nutman, N Rakovitsky, ... Clinical Infectious Diseases 71 (10), 2599-2607, 2020 | 20 | 2020 |
Assessment of dry eye disease in N95 versus surgical face mask wearers during COVID-19 SH Azzam, A Nama, H Badarni, H Asael, WA Dahoud, M Mimouni, ... Indian journal of ophthalmology 70 (3), 995-999, 2022 | 16 | 2022 |
ISARIC clinical data report issued: 14 July 2021 ISARIC Clinical Characterisation Group, JK Baillie, J Baruch, A Beane, ... medRxiv, 2021 | 16* | 2021 |
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations E Carrara, A Savoldi, LJV Piddock, F Franceschi, S Ellis, M Sharland, ... Clinical Microbiology and Infection 28 (1), 66-72, 2022 | 13 | 2022 |
The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey D Ben-David, A Vaturi, E Solter, E Temkin, Y Carmeli, MJ Schwaber, ... Infection Control & Hospital Epidemiology 40 (10), 1094-1099, 2019 | 8 | 2019 |
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance S Frenk, E Temkin, MN Lurie-Weinberger, A Keren-Paz, R Rov, ... Journal of Antimicrobial Chemotherapy 77 (4), 934-943, 2022 | 7 | 2022 |
Spotted fever group rickettsioses in Israel, 2010–2019 R Cohen, T Finn, F Babushkin, Y Paran, RB Ami, A Atamna, S Reisfeld, ... Emerging Infectious Diseases 27 (8), 2117, 2021 | 6 | 2021 |